Roche, ICN deal

ROCZ will exchange its ownership stake in ICN for an 8.7

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE